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In 1981, Krishtal and Pidoplichko described for 
the first time a receptor for H+ that carried in-
ward Na+ currents in mammalian sensory neu-
rons [1, 2]. It was not until 1997 that the group 
of Lazdunski cloned a channel from rat brain 
that was directly activated by H+ and carried an 
excitatory Na+ current [3]. This channel, ASIC1a, 
was just the first member of a small family of H+
-gated channels. Thanks to recent work in many 
laboratories, we now have a clearer picture of 
the physiological function of these H+-gated 
channels and there are clear indications that 
ASICs contribute to the outcome of several 
pathophysiological states.  
 
ASIC1a had been cloned by its homology to the 
amiloride-sensitive epithelial Na+ channel 
(ENaC), with which it shares approximately 25% 
amino acid sequence identity [3]. Other homo-
logues of ASICs include peptide-gated channels 
from polyps [4] and mollusks [5] and mech-
anosensitive channels (the degenerins or “DEG” 
channels) from C. elegans [6]. Thus, ASICs de-
fine a branch of the DEG/ENaC family of ion 
channels. Since the most ancient DEG/ENaC 
channels that have been characterized so far 
are peptide-gated channels from the cnidarian 
Hydra, the HyNaCs [4], and since HyNaCs are 
close relatives of ASICs within the DEG/ENaC 
gene family [4], it is conceivable that H+-gated 
ASICs evolved from peptide-gated channels. 
 
So far, ASICs have been identified exclusively in 
chordates (Figure 1). A single ASIC gene is al-
ready found in the genome of Ciona intestinalis 
[7], an urochordate that belongs to the earliest 
branch in the chordate phylum. Moreover, ASICs 
have been cloned from a jawless vertebrate 
(lamprey) [8], from cartilaginous fish (shark) [8], 
from bony fish (toadfish and zebrafish) [9, 10], 
from chicken [8] and different mammals 
(mouse, rat, human) (Figure 1).  
 
ASICs are defined by their sequence homology; 
functionally,  some  ASICs,  like  ASIC2b  and 
ASIC4, are not sensitive to acid [11-13] and the 
function of those subunits is not always known. 
ASIC2b contributes to proton-sensing by forming 
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heteromeric channels with other ASICs [11]; the 
function of ASIC4, however, is unknown and 
current evidence suggests it is not involved in 
H+-sensing [12]. On the other hand, some DEG/
ENaC members, which do not belong to the 
ASIC branch, are sensitive to H+. For example, 
acid-sensitive channel,  degenerin-like (ACD-1) 
from C. elegans, which is most closely related to 
degenerins, is inhibited by intra- and extracellu-
lar acidification [14]. Another protein from C. 
elegans with sequence homology to DEG/ENaC 
channels  has been dubbed ASIC-1 [15]. Since 
this channel does not belong to the ASIC branch 
of the DEG/ENaC family and functional expres-
sion, let alone H+-sensitivity, has not been de-
scribed, this name is misleading and the protein 
should be renamed. 
 
In the present review we will focus on ASIC1. 
ASIC1 is the most abundant ASIC subunit in the 
mammalian central nervous system (CNS). In 
addition, in the CNS it is the ASIC with the high-
est H+-affinity; ASIC3 is equally sensitive to H+ 
but restricted to the peripheral nervous system 
(PNS) [16]. However, one recent study has re-
ported expression of ASIC3 in rat hypothalamus 
[17]. Moreover, homomeric ASIC1a is the only 
ASIC that is slightly permeable to Ca2+ [3, 18, 
19]. The importance of ASIC1a in the CNS is 
underlined by the fact that it is apparently in-
volved in a number of neurodegenerative dis-
eases (see below). Finally, chicken ASIC1 is the 
only ASIC that has been crystallized [20] and 
the gating mechanism of ASIC1 has been eluci-
dated in some detail. The ASIC1 gene gives rise 
to two variants – ASIC1a and ASIC1b [19, 21]. 
The splice variant ASIC1b is restricted to the 
PNS [21], like ASIC3, and its physiological func-
tions are largely unknown. Moreover, although 
an ASIC1b gene is present in the human ge-
nome, clear evidence for an ASIC1b cDNA in 
humans is lacking. Therefore, we will discuss 
ASIC1b only where it sheds further light on the 
properties of ASIC1a. 
Figure 1: A) Phylogenetic tree illustrating the relationship of selected ASICs. Note that a clear ASIC1 ortholog is pre-
sent in all vertebrate lineages, whereas ASIC3 has so far only been identified in mammalian species. The urochordate 
Ciona contains a single asic gene [7], whereas in mammals the number of asic genes has increased to four. Amino 
acid sequences of selected ASICs were aligned and the tree for the cladogram established by neighbor joining using 
ClustalX (DNAstar software); sequences at the N- and C-termini had been deleted. The related brain-liver-intestine 
Na+ channel (BLINaC) form rat [156] was included for comparison. B) Phylogenetic tree of the chordate phylum. Main 
chordate clades are shown. The color corresponds to the color of ASICs from organisms of these clades in (A). So far, 
no ASICs have been reported from cephalochordates and amphibians; their existence in these clades is, however, 
likely. 
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We will start with a short description of the bio-
physical properties of ASIC1a. We will then dis-
cuss current models of the gating mechanism of 
ASIC1a, review its pharmacology and will then 
briefly  introduce  what  we  know  about  the 
physiological functions of ASIC1a and its impli-
cations in the pathogenesis of neurodegenera-
tive diseases. Most of the discussion will be on 
homomeric ASIC1a; it is known, however, that 
heteromers containing ASIC1a also mediate H+-
gated currents in many neurons. In the CNS, 
homomeric ASIC1a and heteromeric ASIC1a/2a 
are the major ASICs [22-24].  
 
Biophysical properties of ASIC1a 
 
In most studies, ASIC1a starts to open at pH 6.9 
[3, 25]; current amplitude then increases with 
increasing H+ concentrations down to pH 6.0, 
where ASIC current amplitude starts to saturate. 
The H+-concentration response curve can be fit 
by a Hill function and yields half-maximal activa-
tion at pH 6.5 with a Hill-coefficient of approxi-
mately 3 [3, 25]. Very recently, it has been 
shown that in neurons acutely dissociated from 
the amygdala, ASICs containing the ASIC1a sub-
unit are even more sensitive to H+: channels 
opened at pH 7.2 [26]. Whether this extreme 
sensitivity to tiny variations in the H+ concentra-
tions is due to formation of heteromeric chan-
nels, or, more likely, to some modulation by ac-
cessory  proteins  or  other  unknown  factors, 
awaits further studies. 
 
ASIC1a desensitizes completely with a time con-
stant of 1 - 2 sec [3, 19]. Complete desensitiza-
tion means that ASIC1a cannot encode sus-
tained acidification. It recovers from desensiti-
zation within a few seconds [25]. Desensitiza-
tion of ASIC1a starts at pH values slightly below 
pH 7.4 and during prolonged acidification to pH 
values below 7.1 all ASIC channels are in the 
desensitized state [25]. Thus, ASIC1a can enter 
the desensitized state without apparent open-
ing. This steady-state desensitization (SSD) can 
also be fit by a Hill function: for rat ASIC1a it is 
half-maximal at pH 7.25 and has a Hill coeffi-
cient of approximately 10 [25]; for mouse and 
human ASIC1a, it is half-maximal at pH 7.15 
and 6.90, respectively [27]. Thus, SSD seems to 
be a process completely separate from activa-
tion, with a higher H+ affinity.  
 
This conclusion is not necessarily true, however. 
At low H+ concentrations (for rat, between pH 
7.4 and 6.9) channels may open with a low 
probability. The unconcerted opening (and sub-
sequent desensitization) of individual channels 
would not lead to visible currents in whole cell 
measurements and pass unnoticed. In agree-
ment with such a scenario, SSD takes much 
longer than open state desensitization (70 sec, 
at pH 7.05, rather than 1 – 2 sec) [25]. In addi-
tion, in most mutagenesis studies where muta-
tions  changed  the  apparent  H+  affinity  of 
ASIC1a, mutations also affected H+ affinity of 
SSD [25], arguing that both processes are in-
deed intimately linked. Moreover, for the rapidly 
desensitizing ATP receptor P2X1, it has been 
shown that desensitization masks a higher ATP 
affinity of P2X1 activation [28, 29], suggesting 
that the “real” H+ affinity of ASIC1a is that of 
SSD. The E79A substitution in ASIC3 is an ex-
ample of a mutation that shifts the SSD curve to 
10-fold lower H+ concentrations without shifting 
the activation curve [30], suggesting that this 
mutation uncouples SSD from activation gating. 
However,  since the same mutation also en-
hanced desensitization 4-fold [30], it is not ex-
cluded that the faster desensitization may mask 
a higher H+ affinity of ASIC3 activation. In sum-
mary, whether ASIC1a channels can reach the 
desensitized state directly from the closed state 
and if so, to which extent this closed state de-
sensitization contributes to SSD at slight acidifi-
cation are open questions. Irrespective of this 
uncertainty,  all  observations  suggest  that 
ASIC1a is an exquisitely sensitive H+ receptor; if 
H+ affinity were only slightly higher, the channel 
would be chronically desensitized at rest. 
 
Recently, it has been shown that the endoge-
nous opioid peptides dynorphin A and big dynor-
phin shift the SSD curve of ASIC1a to lower H+ 
concentrations limiting the impact of SSD [31]; 
probably  dynorphin  directly  binds to  the ex-
tracellular loop of ASIC1a. This result suggests 
that  ASIC1 should be considered as a new 
nonopioid target for dynorphin action in the 
CNS. 
 
For ASIC3 it has been shown that the curves of 
H+ activation and SSD overlap and that in the 
window of overlap ASIC3 carries sustained cur-
rents [32]. This property endows ASIC3 with the 
capacity to encode also the sustained acidifica-
tion in the window of overlap between pH 7.3 
and 6.7. ASIC1a, however, carries no such win-
dow currents [32] and can, therefore, encode 
Acid-sensing ion channels 
 
 
76                                                                                  Int J Physiol Pathophysiol Pharmacol 2010;2(2):73-94 
only the acidic transients as they may occur 
during synaptic transmission.  
 
Once gated open, the ASIC1a pore has a slight 
selectivity for Na+ over K+ (PNa/PK = 10) [3, 19], 
so that at a membrane potential of -70 mV, 
which is much closer to the K+ than the Na+ 
equilibrium potential, ASIC1a mainly carries an 
excitatory inward current of Na+. In addition, 
homomeric ASIC1a is the only ASIC that has a 
slight permeability to Ca2+ (PNa/PCa = 15) [18, 
19, 33]. The fractional Ca2+ current is, however, 
very  small  [34].  Therefore,  the  Ca2+  influx 
through ASIC1a per se will significantly raise the 
intracellular Ca2+ concentrations only in a micro-
domain close to the channel, if at all. Ca2+ is a 
permeant  blocker  of  ASIC1a,  permeating 
through the channel but also blocking it [3, 35]. 
 
Finally, ASIC1a is not only gated by H+ but also 
permeable to H+ [3, 36]. Not unexpected, rela-
tive H+ permeability is higher than Na+ perme-
ability (PNa/PH < 0.3) [36] but due to the very 
small H+ concentrations  (1 µM at pH 6.0) rela-
tive to the Na+ concentration (~100 mM), the 
fractional H+ current will again be tiny. However, 
it could lead to slight acidification in a microdo-
main surrounding the intracellular mouth of the 
channel. 
 
Tachyphylaxis  is  another  peculiar  feature  of 
homomeric ASIC1a that is specific to this sub-
type [36]. Tachyphylaxis means that repeated 
activation of the channel leads to ever-smaller 
current amplitudes even though the time inter-
val between individual activation is sufficient for 
recovery  from  normal  desensitization.  Thus, 
tachyphylaxis uncovers a second long-lived de-
sensitized state, from which the channel may 
not recover [36]. Tachyphylaxis is linked to H+ 
influx though ASIC1a and its Ca2+ permeability 
[36].  Since  tachyphylaxis  is  especially  pro-
nounced at pH < 6 [36], it is unclear to which 
extent it limits ASIC1a activity in vivo. 
 
The structure of an ASIC: pre-crystal era 
 
ASICs consist of 500 to 560 amino acids. The 
primary structure of each ASIC subunit is char-
acterized by two hydrophobic regions of approxi-
mately 20 amino acids, long enough to span the 
lipid bilayer, rather short termini (35 – 90 amino 
acids) and a large domain between the two hy-
drophobic domains (approximately 370 amino 
acids) (Figure 2A). The transmembrane topology 
of the related ENaC had been established in 
three independent studies [37-39] and revealed 
that the two termini are located in the cyto-
plasm, whereas the domain between the two 
hydrophobic domains, each of which spans the 
membrane once,  forms a large  extracellular 
domain (ECD). It was confirmed that ASICs have 
the same transmembrane topology [40] (Figure 
2B). The first exon, which is different between 
ASIC1a and ASIC1b, thus comprises the intra-
cellular  N-terminus,  the  first  transmembrane 
domain (TMD) and approximately the first one-
third of the ECD (Figure 2A).  
 
A large ECD is not specific to ASICs, but shared 
by all DEG/ENaC channels, although its size can 
vary. Homology between different ASICs is larg-
est  in  the  second  two-thirds  of  the  ECD, 
whereas some parts of the first one-third are 
characterized by considerable sequence diver-
gence. All ASICs have 14 conserved cysteines in 
their ECD (Figure 2A), which likely stabilize the 
structure  of  the ECD by  forming disulphide-
bonds [41]. As almost every membrane protein, 
ASICs carry at least one N-glycan in the ECD. 
ASIC1a has two glycans in the distal part of the 
ECD, whereas ASIC1b carries four glycans: two 
in the distal part, which is identical to ASIC1a, 
and two additional glycans in the proximal part 
[42] (Figure 2A),  which is different between 
ASIC1a and ASIC1b. It has been proposed that 
the two proximal glycans help in shaping the 
structure of the proximal ECD of ASIC1b [42], 
which may therefore be substantially different 
between ASIC1a and ASIC1b. 
 
The number of subunits in a functional channel 
complex has been experimentally addressed in 
several studies, most of the studies focusing on 
ENaC and one study on FaNaC [43]. These stud-
ies came to conflicting results, most of them 
proposing tetramers [43-48] and some nonam-
ers [49, 50]; one recent study found identical 
numbers of the three different ENaC subunits 
(α, β, ), making a trimeric structure a minimal 
subunit composition [51]. 
 
Several studies, most on the ENaC [52-64] and 
some on ASICs [35, 65], suggested that the 
second TMD, especially the first, outer half con-
tributes to the outer entrance and the selectivity 
filter of the ion pore (Figure 2B). ENaC, which is 
characterized by a high Na+ selectivity of its 
pore (PNa/PK > 100), selects ions by molecular 
sieving [54],  largely excluding cations bigger 
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than Na+. The narrowest part of the pore, repre-
senting the ion-selective part of this molecular 
sieve, is formed by three amino acids, which are 
in the middle of the second TMD [54, 56, 60]. In 
all ASICs, these three amino acids are (from N- 
to C-terminus or outside to inside) Gly-Ala-Ser 
(Gly442–Ser444 in rat ASIC1a; Figure 2B), amino 
acids with small side chains. For ENaC, it was 
proposed that the side chains of these three 
amino acids do not point toward the lumen of 
the  pore  but  rather  towards  subunit-subunit 
interfaces [61]. Thus, the backbone of the pep-
tide would face the lumen of the selectivity filter 
and help to coordinate permeating ions; a simi-
lar  situation  is  found  in  the  P-loop  of  K-
channels. The inner entrance to the ASIC pore is 
much less characterized [66].  
 
Surprisingly, the second TMD is identical be-
tween ASIC1a and ASIC1b, yet ASIC1a is perme-
able to Ca2+ whereas ASIC1b is not [19]. The 
difference in Ca2+-selectivity has been attributed 
to the different intracellular N-terminus [19], 
suggesting that this part of the protein helps to 
shape the structure of the ion pore, perhaps by 
long-range allosteric effects. Other studies also 
demonstrate a role for the amino terminus in 
ion selectivity [67] and participation in the inter-
nal pore [66] of ASICs (Figure 2B). 
 
Two amino acids (His-Gly) at the intracellular N-
terminus (Figure 2B) are invariably conserved in 
all DEG/ENaC channels. Also their distance to 
the beginning of the first TMD (approximately 
15 amino acids) is within one or two amino ac-
ids invariable, suggesting that these two amino 
acids have some crucial function for all DEG/
ENaC channels. In ENaC, these two amino acids 
plus a few surrounding amino acids, which are 
also similar across the whole gene family, are 
crucial for the gating of this channel [68, 69], 
defining a ”gating domain“. It is likely that they 
Figure 2: A) Linear model of ASIC1a. The first one-
third of the protein, which is different between 
ASIC1a and 1b, is indicated in light grey. The two 
hydrophobic domains are shown as black boxes. 
The position of the two glycosylation sites of 
ASIC1a are indicated by a branched symbol and 
the two additional glycosylation sites, which are 
specific for ASIC1b, are shown in grey. The 14 
cysteines that are conserved in ASICs are shown 
as black dots; 10 of them cluster in one region. B) 
Model of the transmembrane topology of ASIC1a 
from the pre-crystal era. TMD2 faces the ion pore, 
the three residues (G-A-S) that probably form the 
ion-selective part of the molecular sieve [53, 55, 
59] are magnified in the inset. Residues within the 
intracellular N-terminus that have been implicated 
in contributing to the internal pore of ASIC1a [65] 
or ASIC2 [66] are marked in the inset in dark and 
light blue, respectively. Amino acids in this region 
also determine Ca2+-permeability of ASIC1a [18]. 
The amino acid sequence from rat ASIC1a is 
shown. The two invariably conserved amino acids 
(H-G) in the cytoplasmic N-terminus that are in-
volved in gating of ENaC [67, 68] are marked in 
orange. The four amino acids (D-F-T-C) at the cyto-
plasmic C-terminus that bind to the PDZ domain of 
PICK1 [69, 70] are also magnified in an inset.  
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have a similar function in ASICs.  
 
The function of the cytoplasmic C-terminus for 
ASICs is less well established. Actually the C-
terminus can be quite short (≥40 amino acids) 
in some ASICs. Although the ASIC C-terminus is 
not indispensable for channel activity (see be-
low), it may be quite important for the physio-
logical regulation of ASIC function. For example, 
ASIC1a interacts with its extreme C-terminus 
(Figure 2B) with the PDZ domain of the protein 
interacting with C kinase (PICK1) [70, 71]. No 
interactions have been directly demonstrated 
for ASIC1b, but since the C-terminus of ASIC1b 
is identical to that of ASIC1a, in principle at 
least, this subtype can also interact with PICK1. 
In addition to protein-protein interactions medi-
ated by the C-terminus of ASIC1a, in dorsal root 
ganglion  neurons ASIC1a physically  interacts 
with its N-terminus with annexin light chain p11, 
increasing surface-expression of ASIC1a [72]. 
 
In summary, in the pre-crystal era we had a pic-
ture of ASICs being made of probably four sub-
units, each having an overall simple topology 
with two transmembrane domains, short cyto-
plasmic termini and a large ECD. Although it 
was clear that the ECD has a defined and proba-
bly intricate structure, what this structure would 
exactly look like was completely elusive. 
 
The structure of an ASIC: post-crystal era 
 
A deletion mutant of chicken ASIC1 has been 
crystallized and the crystal structure has been 
resolved at a resolution of 1.9 Å [20]. Since rat 
and  human  ASIC1a  are  90  %  identical  to 
chicken ASIC1, it is very likely that many struc-
tural  details  are  conserved  in  mammalian 
ASIC1. Therefore and to have a common refer-
ence sequence, in this review all amino acids 
are numbered based on the sequence of rat 
ASIC1a. Initially, the chicken ASIC1 structure 
was obtained from a deletion mutant where 
most of the N- and C-termini had been deleted 
[20].  Subsequently,  a  functional  channel,  in 
which only the C-terminus was deleted but not 
the N-terminus with its essential ”gating do-
main“, had been crystallized at a lower resolu-
tion (3 Å) [73]. The main difference between the 
first crystal of a non-functional channel and the 
second crystal of a functional channel was the 
symmetric order of the two transmembrane do-
mains in the functional channel [73]. Thus, the 
high-resolution structure revealed the precise 
structure of the ECD, whereas the low-resolution 
structure added the structure of the transmem-
brane domains and the ion pore. Both proteins 
were crystallized at low pH (pH 5-6 and 6.5, 
respectively), where chicken ASIC1 is desensi-
tized. Therefore, most likely both structures rep-
resent  the desensitized conformation  of  the 
channel. 
 
It came as a big surprise that chicken ASIC crys-
tallized in units of two trimers [20]. Since crys-
tals of the functional chicken ASIC also con-
tained trimers as the basic unit [73], it is highly 
likely that functional ASICs, and probably all 
functional DEG/ENaC channels, are made of 
three subunits. In the meanwhile, a trimeric 
structure has been confirmed for ASIC1a by 
atomic force microscopy imaging [74]. 
 
The ECD of each subunit resembles a clenched 
hand, which is linked to the TMDs via an appar-
ently flexible wrist [20]. The hand domain can 
be divided in five subdomains: palm, finger, 
thumb, and knuckle domains and a β-ball do-
main (Figure 3A). The contacts between the 
subunits  are  in  particular  between  different 
palm domains and the palm domain of one sub-
unit and the thumb domain of another. Promi-
nent subunit interactions are 1) hydrogen bonds 
between Asp78  (all  numbers referring to  rat 
ASIC1a) of one subunit and His73 and Gln420 of 
an adjacent subunit, 2) interactions between 
the loops of β-strands in the palm domain and 
the C terminus of helix α5 of the thumb domain 
of an adjacent subunit, and 3) interactions be-
tween helix α6 of the knuckle that is enveloped 
by a concave surface on the neighboring finger. 
 
Most of the disulphide bonds localize to the 
thumb (Figure 3B), giving it a rigid structure. 
Since the thumb domain has contact with the 
wrist junction via a conserved Trp (Trp287) resi-
due (Figure 3A), its rigid structure may serve to 
faithfully transduce conformational changes to 
the transmembrane ion pore [20].  
 
A peculiar feature of the structure was the clus-
tering of several acidic amino acids within a 
small space, the so-called acidic pocket. This 
pocket is far (45 Å) from the TMDs and is 
formed by intra-subunit contacts between the 
thumb, the β-ball and the finger domains, to-
gether with residues from the palm domain of 
an adjacent subunit [20] (Figure 3A). The acidic 
pocket contains three pairs of acidic residues 
Acid-sensing ion channels 
 
 
79                                                                                  Int J Physiol Pathophysiol Pharmacol 2010;2(2):73-94 
(glutamate or aspartate), which form carboxyl-
carboxylate interactions. The distance of the 
carboxyl groups is so small (2.8 – 3.0 Å; [20]) 
that at least one of the carboxyl groups of each 
pair must be protonated. This means that the 
pKa value of one residue of each pair is several 
units larger than that of isolated Asp or Glu resi-
dues. 
 
TMD1 and TMD2 of the three subunits form α-
helices [73]. Whereas in the crystal of the non-
functional protein TMDs were asymmetric, in 
the crystal of the functional channel they are 
symmetric, providing the structure of the ion 
pore  in  the  desensitized  conformation.  The 
TMD2 helices are closest to the three-fold axis, 
are tilted by ~50o with respect to the membrane 
and cross each other in the middle of the mem-
brane bilayer [73]. Thus, in line with previous 
functional studies [52-65], TMD2 helices proba-
bly line the ion pore. The TMD1 helices make 
most contacts with the lipid bilayer but also with 
TMD2 helices of the same subunit and the 
TMD1 and TMD2 helices of adjacent subunits. 
 
In the desensitized conformation, two cation-
binding sites have been revealed by soaking the 
crystal in solutions containing Cs+. In both sites, 
Cs+ is coordinated by six ligands arranged in a 
trigonal antiprism geometry. At site 1, Cs+ is 
coordinated by three side chain carboxyl groups 
of Asp432. At site 2, ligands consist of either 
Figure 3: A) Model of the transmembrane topology of ASIC1a from the post-crystal era (based on reference [19]). 
Three features of the structure and their crucial amino acids are magnified in the insets: the acidic pocket, the ball-
and-socket joint and the Ca2+ binding site in the ion pore. Binding of a Ca2+ ion in the acidic pocket is hypothetical. 
Note that all amino acids are numbered based on the sequence of rat ASIC1a. B) Linear model of ASIC1a highlighting 
the relation of the primary sequence to the five subdomains of the ECD. It becomes apparent that the α-helices of the 
finger, thumb and knuckle subdomains are contained within contiguous stretches of the polypeptide chain, whereas 
the palm and β-ball domains are formed by β-sheets that are scattered over the polypeptide chain. Those β-sheets 
connect the finger, thumb and knuckle subdomains. Note also that most of the cysteines (black dots) cluster within 
the thumb subdomain (green), giving it a rigid structure. The structure of the cytoplasmic termini is unresolved. 
Acid-sensing ion channels 
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main-chain carbonyl oxygen atoms from Gly431 
or side chain oxygen atoms from Asp432. More-
over, it was suggested that main-chain carbonyl 
oxygen atoms, derived mainly from glycine resi-
dues,  also  coordinate  permeant  ions in  the 
open channel. Thus, G431 and G435 could build a 
third ion-binding site in the open conformation 
of the channel [73]. Other candidates for gly-
cines involved in ion coordination are G438 and 
G442 [73]. G442 is the first of the three residues 
proposed by earlier studies to form the selectiv-
ity filter [54, 56, 60] (Figure 2B).  
 
In the desensitized conformation, three vesti-
bules can be discerned in the ECD, along the 
central axis of the channel [73] (Figure 4). The 
upper vestibule is in direct contact with the ex-
tracellular solution, whereas the central and the 
extracellular vestibule, which is situated at the 
height of the outer surface of the membrane, 
are separated from each other and the upper 
vestibule by constrictions. If these constrictions 
would be wider in the open channel, they would 
form a central tunnel, constituting a pathway for 
ions to the pore. Cations would be concentrated 
within the vestibules along the central tunnel by 
several acidic residues, clustered in the central 
and extracellular vestibules (Figure 4). In addi-
tion to this putative central pathway for ions, in 
the desensitized conformation, there is direct 
access to the extracellular vestibule through 
three lateral fenestrations at the wrist of the 
ECD.  
 
Even with the lateral access pathway to the ex-
tracellular  vestibule,  ions  cannot  permeate 
through the pore because, in the desensitized 
conformation, TMD2 helices cross each other in 
the middle of the membrane bilayer. Thus, the 
helices apparently change their conformation 
during desensitization, constricting the ion pore. 
This constriction therefore constitutes the de-
sensitization gate – a physical block of the ion 
pore (Figure 4).  Close packing of  the three 
TMD2 helices at the constriction is made possi-
ble by Gly435. 
 
The speed of the desensitization is determined 
by three amino acids in the proximal ectodo-
main (S83-T85) [10]. Moreover, a residue in the 
immediate vicinity (E79) is modified by cysteine-
modifying reagents in the closed but not the 
desensitized conformation [30], suggesting that 
this residue undergoes a conformation change 
during desensitization gating of the channel. 
Together these results suggest that the loop 
encompassing residues E79-T85, which localizes 
between the palm and the β-ball domains, un-
dergoes a conformation change during desensi-
tization gating that determines the speed of 
Figure 4: Model of ASIC1a showing the 
three vestibules in the ECD and the lat-
eral access to the extracellular vestibule 
via a lateral fenestration (based on refer-
ence [72]). Acidic amino acids that line 
the central and extracellular vestibules 
are indicated; they are numbered based 
on the sequence of rat ASIC1a. The nega-
tive charge of their side chains could 
attract cations to the vestibules. 
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desensitization. 
 
In summary, the crystal structure of chicken 
ASIC1 provides an invaluable picture of the intri-
cate three-dimensional structure of the ECD and 
the ion pore. It suggests models for ion permea-
tion and selectivity in these channels and, as we 
will see, it also suggests models for H+-gating of 
ASICs. One has to keep in mind, however, that 
the chicken ASIC1 structure is a snapshot of the 
desensitized state of the channel. A clear pic-
ture of the conformational changes accompany-
ing ASIC gating needs additional crystal struc-
tures of, ideally, the closed and the open states. 
In the absence of these structures, the first crys-
tal  structure  can  nevertheless  guide  future 
structure-function  studies  and  greatly  refine 
models of ASIC gating. 
 
How to gate an ASIC by H+ 
 
In principle, titration of a single amino acid of an 
ASIC, for example in the ECD, could induce a 
conformational change, opening the ion pore. 
Current models of ASIC gating, however, invoke 
a more complicated process to explain ASIC 
gating.  
 
An initial observation providing a clue to ASIC 
gating came from the observation that extracel-
lular Ca2+ ions modulate the apparent H+ affinity 
of ASIC1: high [Ca2+]e decreases apparent H+ 
affinity (higher H+ concentrations are needed to 
open the pore) and low [Ca2+]e increases appar-
ent  H+  affinity  (lower  H+  concentrations  are 
needed to open the pore) [25]. To explain these 
findings, it was proposed that Ca2+ stabilizes the 
closed state of the channel and that H+ dis-
places Ca2+ from its binding site,  effectively 
competing with Ca2+ for this binding site [25]. 
This model was then extended for ASIC3 by pro-
posing that a Ca2+ ion in fact blocks the open 
ASIC pore. According to this model, H+ would 
gate an ASIC open by unblocking the ion pore 
with no accompanying conformational change 
[75].  
 
Substitution of D432 and E425 at the N-terminal 
end of TMD2 by neutral amino acids disrupted 
pore block of ASIC1a by Ca2+ [35]. The crystal 
structure of cASIC1 confirmed that D432 and 
E425 are accessible from the aqueous phase 
within  the  extracellular  vestibule;  moreover, 
D432 forms a putative binding site for cations at 
the bottom of the extracellular vestibule [73] 
(Figure 3A), suggesting that substitution of D432 
and E425 disrupted the Ca2+ binding site in the 
outer pore of ASIC1a. In addition, voltage clamp 
fluorometric measurements showed that E425 
undergoes a significant reorganization following 
extracellular  acidification  [76],  in  agreement 
with the idea that such a movement is associ-
ated with relief of Ca2+ blockade. This Ca2+ bind-
ing site mutant, therefore, allowed testing of the 
pore block model. According to this model, dis-
ruption of the Ca2+ binding site should have 
three effects: first and most importantly, the ion 
pore should be constitutively open, second, the 
channel should be no longer gated by H+ and 
third, Ca2+ should no longer modulate the ap-
parent affinity for H+. All three predicted effects 
were not observed: mutant channels were not 
constitutively open, they were still gated by H+ 
and their apparent H+ affinity was still modu-
lated by Ca2+ [35]. These results effectively rule 
out the possibility that pore block by Ca2+ can 
fully explain gating of ASIC1. Examination of 
single channel recordings of ASIC1 from toad-
fish also argued against the Ca2+ pore block 
model and favored an allosteric model to ex-
plain ASIC gating [77]. Moreover, modulation by 
a spider toxin (psalmotoxin 1, see below) of chi-
meras between ASIC1a and 1b suggested the 
existence of partially-liganded open states of 
ASIC1 [78], a finding, which is in agreement 
with a Monod-Wyman-Changeux model for coop-
erativity in allosteric proteins.  
 
Channels with the Ca2+ binding site mutations 
(D432 and E425) had, however, reduced affinity 
for H+, a smaller Hill co-efficient and modulation 
by Ca2+ was less pronounced [35], suggesting 
that pore block by Ca2+ contributes to ASIC gat-
ing. This interpretation suggests the existence 
of two Ca2+ binding sites involved in ASIC gating: 
one at the outer entrance to the ion pore, cru-
cial determinants are D432 and E425, and an-
other one at a different location within the ECD. 
The acidic pocket is suspicious of such a sec-
ond putative Ca2+ binding site within the ECD 
[20].  Pairs of acidic amino acids within the 
acidic pocket are D237-D349, E238-D345, and E219-
D407 (Figure 3A); E79-E416 defines a fourth pair 
outside the acidic pocket [20]. 
 
Since the crystal probably represents the struc-
ture of the desensitized conformation, it has 
been hypothesized that, in the closed state, the 
acidic pocket held a Ca2+ ion that was displaced 
upon acidification when one of the acidic resi-
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dues of each pair became protonated [20]. This 
is an attractive and plausible hypothesis that is 
supported by the experimental finding that E79, 
which is in an acidic pair, is inaccessible for 
cysteine-modifying reagents in the desensitized 
but not the closed state [30]. Moreover, molecu-
lar simulations of cation binding to the structure 
of chicken ASIC1 revealed that Ca2+ binds to the 
acidic pocket, but only when all three pairs of 
acidic residues are charged, and that H+ binding 
inhibits Ca2+ binding at this site [79]. Evidence 
for cation binding was especially strong for the 
two pairs D237-D349 and E238-D345 [79]. Individual 
mutations of amino acids of the acidic pocket 
have rather modest effects on ASIC gating [20, 
80], however, and even combined substitution 
of all four amino acids from the two critical pairs 
(D237-D349, E238-D345) did not disrupt proton gat-
ing of an ASIC [81]. These results suggest that 
there are further determinants of ASIC gating. 
Indeed  molecular  simulations  suggested  the 
surface residue pairs D298-D331 and E338-E342 as 
additional potential candidates for H+ sensing 
sites of ASIC1a [79]; these sites are not con-
served in other H+-sensitive ASICs (e.g. ASIC3), 
however, suggesting that if they have a role in 
ASIC gating it must be a rather modulatory role.  
 
In addition to titration of acidic residues within 
Ca2+-binding sites, H+ may also titrate amino 
acids that contribute to open gating of an ASIC 
by an allosteric mechanism. Indeed some years 
ago, a histidine that is highly conserved in ASICs 
has already been shown to be important for H+ 
gating of ASIC2a [82]. ASIC1a has two adjacent 
histidines at the corresponding position (H72/
H73) and in a large screen for amino acids in-
volved in gating of ASIC1a, these same two his-
tidines  were  found  to  be  indispensable  for 
ASIC1a gating [80], confirming the importance 
of these His residues. In this screen, D78 and 
E79 were also found to be important for ASIC1a 
gating, but only when combined with the Ca2+ 
binding site mutations in the pore (D432 and 
E425) [80]. Interestingly, in the desensitized con-
formation, D78 forms a hydrogen bond with H73 
[20] and E79 forms a carboxyl-carboxylate pair 
with E416, supporting an important function of 
these two residues. Molecular simulations sug-
gested that the E79-E416 pair, in contrast to the 
pairs from the acidic pocket (D237-D349, E238-
D345,  and E219-D407),  preferentially binds Na+ 
over Ca2+ ions [79], suggesting a role in ion per-
meation for E79. Although their exact role is still 
unknown, collectively current evidence suggests 
a crucial role for H72/H73, D78, and E79 in ASIC 
gating. Indeed the presence of these amino 
acids has been successfully used to predict H+-
sensitivity of ASIC1b from shark [83].  
 
Several studies used chimeric approaches to 
identify the regions that are responsible for dif-
ferential H+ sensitivity of different ASICs. Such 
regions do not necessarily contain crucial H+ 
binding sites, however. In one such approach 
with chimeras between rat ASIC1a and 1b, two 
amino acids (K105N106) that localize to the finger 
domain were identified where substitutions con-
vert the relatively high apparent H+ affinity of 
ASIC1a into the lower affinity of ASIC1b [25]. 
Molecular simulation also suggested that the 
finger domain moves during gating [79]. In an-
other study with chimeras between rat ASIC1a 
and 2a, two larger regions (from amino acid 87 - 
197 and from 323 – 431) were identified that 
specify the different H+ sensitivities of these two 
ASICs [84]. ASIC2a has a rather low H+ sensitiv-
ity, however, explaining the larger regions nec-
essary to swap sensitivities.  
 
Based on current evidence it has been pro-
posed [80] that upon acidification, H73 (and 
perhaps H72) gets protonated, which induces a 
conformational change, facilitating the displace-
ment of Ca2+ ions from its binding sites in the 
pore  and  the  acidic  pocket.  Concomitantly, 
charged residues of the Ca2+ binding sites get 
protonated and form the carboxyl-carboxylate 
pairs. The conformational change is probably 
accompanied by a movement of the palm do-
main relative to the thumb domain. Movement 
of the thumb domain is then likely transferred to 
the TMDs to open the ion pore. Voltage clamp 
fluorometry indeed suggests that the pre-TMD2 
region changes its conformation upon acidifica-
tion [76]. The crucial role of the thumb domain 
in transferring the conformational changes of 
the ECD to the TMDs is suggested by the close 
contact of Tyr71 and Trp287 (at the base of the 
thumb in immediate contact to the wrist junc-
tion) in the cASIC crystal [20]. It has been pro-
posed that these two residues form a ball-and-
socket  joint  to  transduce  conformational 
changes of the ECD to the TMDs [20] (Figure 
3A). Moreover, the importance of the interaction 
between Y71 and W287 for ASIC gating has re-
cently been experimentally confirmed [81]. In 
addition,  amino  acid  changes  in  the  region 
around W287 determine the differential H+ sensi-
tivity of SSD of mouse and human ASIC1a [27]. 
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Desensitization would then be accompanied by 
a movement of the loop encompassing residues 
E79-T85, which is probably accompanied by rota-
tion of the adjacent residues D78 towards H73 
and E79 towards E416, and finally by constriction 
of the ion pore in the middle of TMD2. This is a 
tentative and hypothetical model. What is quite 
clear is that ASIC gating critically involves sev-
eral residues scattered over the ECD, with resi-
dues at the wrist junction having a central role. 
 
Pharmacology of ASIC1 
 
The pharmacology of ASIC inhibitors and their 
therapeutic potentials have been reviewed pre-
viously [85-87]. Here we summarize recent find-
ings from the view of structure-function relation-
ships.  
 
Chemically, there are three classes of ASIC in-
hibitors:  metal  ions,  polypeptide  toxins,  and 
small-molecule inhibitors (table 1). Besides Ca2+ 
and Mg2+, a number of divalent and trivalent 
metal ions inhibit ASICs. PcTx1 is a cysteine-rich 
high-affinity polypeptide toxin purified from a 
tarantula venom. Amiloride, A-317567, nafamo-
stat and diarylamidines are examples for syn-




Currently zinc, copper, lead, nickel, and cad-
mium have been documented to affect ASIC1a. 
Zinc (Zn2+), an endogenous trace element, in-
hibits  homomeric  ASIC1a  and  heteromeric 
ASIC1a/2a with nanomolar affinity, without af-
fecting  currents  mediated  by  homomeric 
ASIC1b, ASIC2a, or ASIC3 [88]. In agreement 
with high-affinity  Zn2+-inhibition of  the major 
ASICs in the CNS (ASIC1a and ASIC1a/2a), che-
lation of trace amounts of Zn2+ by TPEN, a Zn2+/
Fe2+ chelator with low affinity for Ca2+, potenti-
ates approximately two-fold ASIC currents in 
cultured mouse cortical neurons [88]. Likewise, 
sulfhydryl-containing reducing agents like dithio-
threitol potentiate ASIC currents in hippocampal 
neurons, mainly by chelating metal ions that 
tonically inhibit  ASIC1a and ASIC1a/2a [89]. 
Homomeric ASIC1a is more strongly inhibited by 
Zn2+ than heteromeric ASIC1a/2a [88]. At much 
higher (micromolar) concentrations, Zn2+ has an 
opposite  effect  and  potentiates  currents 
through homomeric  ASIC2a and heteromeric 
ASIC1a/2a (EC50: ~100 µM), but not through 
homomeric ASIC1a [82]. In addition, such high 
concentrations of Zn2+ slow the decay time con-
stant of ASIC currents in hippocampal neurons 
[90]. High-affinity Zn2+-block depends on K133 in 
Table 1: Inhibitory constants (IC50) of different inhibitors at homomeric ASIC1a and ASIC currents in cul-
tured neurons. ND, not determined  
Inhibitor 
  
IC50 at ASIC1a 
[µM] 




Zn2+ 0.007 ~0.015 [87] 
Cu2+ ND ~50 [90] 
Pb2+ ~5 ~10 [91] 
Cd2+ no inhibition ND [92] 
Ni2+ ~600 ND [92] 
PcTx1 ~0.001 (at pH 7.4) ND [95] 
        
amiloride 10 10 - 50 [3] 
nafamostat ~15 ND [121] 
ibuprofen ~350 ND [122] 
flurbiprofen ~350 ND [122] 
A-317567 ND 2 - 30 [123] 
DAPI ND 3 [124] 
pentamidine ND 40 [124] 
hydroxystilbamidine ND 1.5 [124] 
diminazene 2 - 3 0.3 [124] 
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the  ECD  of  ASIC1a  [88]  whereas  Zn2+-
potentiation depends on H162 and H339 in the 
ECD of ASIC2a [82].  
 
Micromolar concentrations of copper (Cu2+) in-
hibit  ASIC currents  in  cultured hypothalamic 
neurons (IC50: ~50 µM) [91] and the neurotoxic 
metal ion lead (Pb2+) strongly and reversibly 
blocks  ASIC1a-containing  homo-  and  hetero-
meric channels (IC50: ~5 µM) [92]. Nickel (Ni2+) 
and cadmium (Cd2+) affect some ASIC currents 
at high concentrations (1 mM) [93]. At this con-
centration, Ni2+ inhibits homomeric ASIC1a and 
heteromeric ASIC1a/2a [93]. In contrast, Cd2+, 
up to 1 mM, does not affect homomeric ASIC1a 
currents [93]. Since Cd2+ blocks voltage-gated 
calcium channels [94, 95], it can be used as a 
pharmacological  tool  to  distinguish  between 
ASIC1a and voltage-gated calcium channels as 





Psalmotoxin 1 (PcTx1) is a polypeptide toxin 
isolated from the venom of the South American 
tarantula Psalmopoeus cambridgei and specifi-
cally inhibits homomeric ASIC1a with an IC50 of 
~ 1 nM. PcTx1 does not inhibit other ASIC sub-
types or voltage-gated ion channels [96] and 
has already proven to be a useful pharmacologi-
cal tool for probing the functions of ASIC1a in 
vivo [97-100]. PcTx1 consists of 40 amino ac-
ids, containing 6 cysteines that form three disul-
fide bridges. The solution structure of PcTx1 has 
been determined [101] and, interestingly, PcTx1 
is structurally similar to a class of gating modi-
fier toxins of voltage-gated ion channels, such 
as Hanatoxin 1 [101]. Like Hanatoxin 1, PcTx1 
has a canonical inhibitor cysteine knot (ICK) 
scaffold, which possesses an embedded ring 
formed by two disulfide bonds and their con-
necting backbone segments which is threaded 
by a third disulfide bond [101, 102]. Spider tox-
ins most often modify the voltage dependence 
of voltage-gated ion channels [103-106] or slow 
their  inactivation  kinetics  [107,  108].  PcTx1 
inhibits ASIC1a in a similar manner: it increases 
the apparent ligand affinity of ASIC1a [109]. 
Since ASIC1a is activated by H+ at concentra-
tions that are only slightly higher than the rest-
ing H+ concentrations, this increase in H+ affinity 
is sufficient to transfer ASIC1a channels into the 
desensitized state. Since ASIC1 has been impli-
cated in the neurodegeneration accompanying 
ischemic stroke and since it contributes to ax-
onal  degeneration  in  autoimmune inflamma-
tion, this finding implies a new approach to in-
tervene with ASIC1a activity: to pharmacologi-
cally facilitate its steady-state desensitization by 
slightly increasing its H+ affinity. Such an ap-
proach is hampered, however, by the compara-
tively low H+ affinity of SSD of human ASIC1a 
[27].  
 
PcTx1 does not inhibit ASIC1b but rather in-
creases the proton affinity of ASIC1b and shifts 
its  pH-activation  curve  to  higher  pH values. 
PcTx1  directly  opens  ASIC1b  under  slightly 
acidic conditions. In addition, PcTx1 significantly 
slows the desensitization process of ASIC1b, 
but not of ASIC1a. These data strongly support a 
model of state dependent binding, i.e. PcTx1 
has different affinities for the closed, open, and 
desensitized states of the channels. For ASIC1a, 
it stabilizes the desensitized state promoting 
SSD, whereas for ASIC1b, it stabilizes the open 
state promoting channel opening [78].  
 
First hints on the PcTx1 binding site came from 
mutagenesis  studies,  in  which  chimeras  be-
tween ASIC1a and ASIC2a and/or 1b were as-
sessed for binding of radiolabelled PcTx1 [110] 
or for PcTx1-inhibition of proton-gated currents 
[78, 110]. One of these studies identified amino 
acids 167-185 in the ECD of ASIC1a that deter-
mines a high PcTx1 affinity of the desensitized 
state of ASIC1a [78]. Another study identified 
the same region plus a second region (amino 
acids 271-369) in the ECD [110]. The involve-
ment of both domains in PcTx1 binding was 
recently  confirmed by computational  docking 
simulations [111, 112],  which revealed that 
PcTx1 binds to a pocket in the ECD of ASIC1a 
which is formed by four structural motifs: the 
two stretches identified with the chimeric chan-
nels (amino acids 167-185 and the distal part 
of stretch 271-369), an additional region com-
prising amino acids 113-129, and E219 [111, 
112].  Moreover,  molecular  docking  revealed 
that PcTx1 binds at the interface of two sub-
units and that the domains constituting the high
-affinity binding site are located on two adjacent 
subunits [111, 112]. The crucial role of the dis-
tal part of the stretch from amino acids 271-
369 was recently confirmed by the finding that 
the F350L substitution (F352 in human ASIC1a) 
completely eliminated the modulation of ASIC1a 
by  PcTx1  [84].  Since  PcTx1  competes  with 
dynorphin for binding to ASIC1a [31], the bind-
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ing site for  dynorphin may overlap with the 
PcTx1 binding site. 
 
Recently,  it  was  demonstrated  that  PcTx1 
strongly activates chicken ASIC1a even at neu-
tral pH [34]. Therefore, PcTx1 functions as an 
allosteric agonist for cASIC1, providing a novel 
tool for elucidating the gating mechanism of 
cASIC1. This finding also provides an explana-
tion why a tarantula venom contains a toxin that 
targets ASIC1. From an evolutionary point of 
view, PcTx1 may have been generated by the 
tarantula as an activator rather than as an in-
hibitor of ASICs so as to ward off its potential 
predators (such as birds) because activating 
ASICs would cause pain or inflammation. Similar 
examples from nature are vanillotoxins that are 
contained within the venom of the same taran-
tula species (Psalmopoeus cambridgei). Vanil-
lotoxins share high homology and a conserved 
cysteine bridge pattern with PcTx1 and directly 
open TRPV1 channels [113] to cause pain as a 
defending strategy. The result that PcTx1 di-
rectly gates chicken or rat ASIC1, thus, supports 
the idea that ASICs are involved in pain percep-
tion. Therefore, blocking ASIC1 may have bene-
ficial effects in relieving pain. Indeed it has been 
shown that PcTx1 has potent analgesic proper-
ties against thermal, mechanical, chemical, in-





The  diuretic  amiloride  is  an  open  channel 
blocker plugging the ion pore [35] and is viewed 
as a prototype blocker of ASIC channels. Amilo-
ride blocks ASIC1a currents with an IC50 of 10 
µM [16, 114]. It is not very selective and inhib-
its, among others, ENaC, T-type calcium chan-
nels, and the sodium-proton exchanger [86]. In 
peripheral sensory neurons, amiloride has been 
used to suppress acid-induced pain [115, 116], 
whereas  in  CNS  neurons,  it  reduces  acid-
mediated ischemic neuronal injury and axonal 
degeneration [97, 98]. Both effects are poten-
tially mediated by the inhibition of ASICs. 
 
Nafamostat, a synthetic, competitive serine pro-
tease inhibitor that is clinically used for the 
treatment of disseminated intravascular coagu-
lation and acute pancreatitis [117-121], has 
recently been identified as an inhibitor of ASICs 
[122]. In contrast to amiloride, nafamostat in-
hibits ENaC (IC50: ~1 mM) less potently than 
ASICs (IC50: ~2 – 70 µM, depending on the sub-
type).  Non-steroidal  anti-inflammatory  drugs, 
such as diclofenac and ibuprofen, directly in-
hibit ASICs in nociceptors but with relatively low 
potency [123]. Ibuprofen and its analogue flur-
biprofen inhibit ASIC1a with an IC50 of 350 µM, 
whereas diclofenac inhibits ASIC3 (IC50: 100 
µM) but not ASIC1a [123]. A-317567, a novel 
non-diuretic blocker, inhibits three distinct types 
of native ASIC currents of acutely dissociated 
adult rat dorsal root ganglion (DRG) neurons 
[124].  
 
Through a small  scale screen,  anti-protozoal 
diarylamidines, including diminazene, hydroxys-
tilbamidine (HSB), and pentamidine were re-
cently identified as potent inhibitors of ASICs in 
primary cultured hippocampal neurons as well 
as of ASICs over-expressed in CHO cells or in 
Xenopus  oocytes  [125].  Diarylamidines  have 
been widely used for the treatment of protozoal 
diseases such as trypanosomiasis and leishma-
niasis since the 1930s [126-128]. Diarylamidi-
nes such as diminazene are lead compounds 
that point to a new route to identify new potent 
and selective inhibitors of ASICs. Diminazene is 
the most  potent  small  molecule inhibitor  of 
ASICs known so far (IC50: 0.3 µM, measured in 
cultured hippocampal neurons). It has distinct 
potency on different ASIC subtypes.  It blocks 
homomeric  ASIC  currents  expressed in  CHO 
cells with a rank order of potency 1b > 3 > 2a > 
1a.  Intriguingly,  anti-parasitic  diarylamidines 
comprise more than 30 members and the fam-
ily number is rapidly increasing due to medical 
needs in the treatment of pneumocystosis, Afri-
can trypanosomiasis and leishmaniasis. Thus, it 
is feasible to select these compounds from the 
chemical family of diarylamidines to test their 
inhibitory effects on ASICs and to possibly iden-
tify new selective and potent ASIC blockers with 
therapeutic potential.  
 
Comparison of nafamostat with diarylamidines 
reveals that both are dications which are gov-
erned by amidine/guandine groups at their ter-
mini, with variable bulk (like benzene rings) on 
the outer edge of the molecule linked by mo-
lecular bridges of varying length and composi-
tion. Their difference lies in that nafamostat has 
a guanidine group at  one terminus and an 
amidine group at the other, while diarylamidines 
have amidine groups at both ends. It is not sur-
prising that dicationic diarylamidines or nafamo-
stat block ASIC potently as the ectodomain of 
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ASICs has a large number of negatively charged 
amino acids [80].   
 
A “patchdock” computation technique was used 
to dock nafamostat, diminazene, HSB and pen-
tamidine,  respectively,  to  the  ASIC1  crystal 
structure and to analyze possible binding do-
mains of these compounds [125]. This analysis 
suggests that these dicationic compounds likely 
bind to a groove formed by part of the β-ball and 
palm domains of ASICs [125]. Specifically, resi-
dues in a stretch from F174 to L207 shape this 
groove [125]. Thus, this domain partly overlaps 
with the PxTc1 binding site. So far, there is no 
selective  small-molecule  inhibitor  for  ASICs, 
mainly because the potency of the known inhibi-
tors is relatively low. Further structure-function 
studies and larger screens based on the cASIC1 
crystal structure and the common template of 
diarylamidines may lead to the identification of 
more potent and subtype-specific blockers of 
ASICs. 
 
Regarding the pharmacological classification of 
known  ASIC  inhibitors,  they  fall  into  three 
classes:  gating  modifiers  (PcTx1),  non-
competitive antagonists (probably diminazene 
and nafamostat)  and  un-competitive  antago-
nists (pore blocker amiloride). Ca2+ and Mg2+ 
might be competitive antagonists.  
 
Physiological functions and pathophysiology of 
ASIC1 
 
ASICs are predominantly, though not exclusively, 
expressed throughout the PNS and CNS. In the 
CNS, ASIC1a is abundantly present in the hippo-
campus, cortex, striatum, olfactory bulb and 
elsewhere, with a particularly high expression in 
the amygdala [129]. Low pH-induced ASIC cur-
rents are detected in virtually every cultured 
neuron from spinal dorsal horn [130], cortex 
[97], and hippocampus [22, 23]. In contrast, 
ASIC currents are not detectable in glial cells 
[131, 132] and we were unable to detect ASIC 
currents by puff-application of pH 5.8 to micro-
glia in acute cortical slices (X.C., unpublished). 
However, the presence of ASIC-like currents has 
been documented in cells of the oligodendro-
cyte lineage [133, 134] and in glioblastoma 
cells [132].  
 
What is the function of ASICs in central neu-
rons? Synaptic vesicles are acidic [135] and it is 
conceivable that the release of the content of 
the synaptic vesicles sufficiently acidifies the 
synaptic cleft [136] to activate ASICs. In agree-
ment with such a scenario, in transfected cul-
tured hippocampal neurons, ASIC1a has a syn-
aptic pattern of distribution and co-localizes 
with the postsynaptic marker PSD95 but not 
with the axonal marker dephospho tau-1 [137]. 
ASIC1a transfected into hippocampal slices also 
has somatodendritic localization and is present 
in most spines [138]. Moreover, ASIC2, which 
can tether to PSD95 (in contrast to ASIC1a), 
facilitates ASIC1a localization at dendritic 
spines by direct association with ASIC1a [139]. 
In addition, there is evidence that ASIC1a modu-
lates the density of dendritic spines [138]. The 
presumably postsynaptic location of ASIC1a 
together with its Na+-selectivity, thus, suggests 
that ASIC1a contributes to the excitatory postsy-
naptic current in many neurons.  
 
In agreement with this hypothesis, knock out of 
the asic1 gene in mice reduces excitatory post-
synaptic potentials during high-frequency elec-
tric stimulation and impairs long-term potentia-
tion (LTP) at Schaffer collateral-CA1 synapses in 
the hippocampus [137]. In contrast, baseline 
synaptic transmission is normal in those mice 
[137]. It is plausible that ASIC1a facilitates neu-
ronal depolarization especially during high fre-
quency stimulation and thus may promote the 
opening of NMDA receptors, activation of which 
is a central feature of CA1 LTP. However, the 
exact role of ASIC1a in LTP is not fully under-
stood. Behaviorally, ASIC1a null mice display 
defective spatial learning and defective cerebel-
lum-dependent eyeblink conditioning [137].  
 
Consistent with the robust expression of ASIC1a 
in lateral and basolateral nuclei of the amygdala 
and in the hippocampus [129, 137, 140], mice 
lacking ASIC1 also exhibit deficits in multiple 
fear-related behaviors including unconditioned 
fear, and the acquisition and retention of condi-
tioned  fear  [129,  140].  Conversely,  over-
expressing ASIC1a throughout the brain in a 
transgenic mouse enhances context fear condi-
tioning [141]. Restoring ASIC1a function specifi-
cally in the amygdala of ASIC1 knockout mice 
with a viral vector rescues fear memory but not 
unconditioned  fear  responses  [142].  Finally, 
ASIC1a was recently shown to be a chemosen-
sor in the amygdala detecting carbon dioxide 
and acidosis that elicits fear behavior [26]. In 
line with an important role in the fear circuit, 
genetically disrupting or pharmacologically in-
hibiting ASIC1 has antidepressant-like effects 
[143], establishing ASIC1a as a new possible 
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target to combat depression.  
 
Somewhat contradictory to its excitatory role, 
some studies  point  to  an  inhibitory  role  of 
ASIC1a.  One  recent  study  suggested  that 
ASIC1a could exert some protective effects in 
the brain under epileptic conditions [99]. This 
study combined genetic, pharmacological, and 
electrophysiological  approaches  with  animal 
behavioral  analysis  to  examine  how ASIC1a 
works under epileptic conditions. It was found 
that ASIC1a facilitates termination of seizures 
rather  than  causing  neuronal  over-excitation 
[99]. ASIC1a reduces seizure severity, shortens 
seizure duration, and promotes seizure termina-
tion [99]. Transgenic over-expression of ASIC1a 
had beneficial effects without affecting seizure 
threshold, while ASIC1a ablation had opposite 
effects and increased seizure severity and re-
duced postictal depression of epilepsy and thus 
increased seizure-caused mortality [99]. Thus, 
there is solid evidence that ASIC1a mediates 
the antiepileptic effects of extracellular acidosis 
during epilepsy. But how can an excitatory chan-
nel dampen neuronal over-excitation? To ex-
plain this paradox, a mechanistic model was 
proposed that activation of ASIC1a in inhibitory 
interneurons of the hippocampus, which have 
larger ASIC currents than excitatory pyramidal 
neurons [99], could increase the inhibitory tone 
and thereby attenuate epileptic activities [99]. 
Thus, according to this model, ASIC1a is an exci-
tatory ionotropic receptor, but its predominant 
expression in inhibitory neurons would increase 
the inhibitory tone in a network during ASIC1a 
activation.  
 
A similar model may explain increased (rather 
than reduced) pain sensitivity in mice with a 
loss  of  ASIC  function.  A  dominant-negative 
ASIC3 subunit assembles with other ASIC sub-
units and transgenic expression of this subunit 
leads to a complete loss of ASIC-like currents to 
pH 5.0 stimulation in DRG neurons [144]. Unex-
pectedly, in these transgenic mice sensitivity to 
mechanic and inflammatory pain is increased 
rather than reduced [144]. Similarly, ASIC3 null 
mice show enhanced behavioral responses to 
high-intensity  nociceptive  stimuli  [145].  This 
increased pain  sensitivity  may  again  be  ex-
plained by the precise location of ASICs within 
the pain pathway.  
 
But there are also observations suggesting that 
ASICs might down-regulate excitability of individ-
ual neurons. For example, presynaptic release 
probability is enhanced in hippocampal neurons 
from ASIC1 null mice [146]. Moreover, in the 
retina ASIC2a negatively modulates rod photo-
transduction and protects the retina from light-
induced degeneration [147]. ASIC1a, however, 
is a positive modulator of cone phototransduc-
tion and adaptation [148]. Although the exact 
role of different ASICs in signal transduction in 
the retina is unknown, these studies support 
the possibility that ASICs, under certain circum-
stances, might function as negative regulators 
instead of depolarizing elements in the course 
of synaptic transmission.  
 
In addition to its roles in fear conditioning and 
seizure  termination,  ASIC1a  apparently  gets 
activated during the course of a number of neu-
ropathological syndromes such as brain ische-
mia, autoimmune inflammation, or inflamma-
tion-associated pain. A prolonged acidosis is 
common to  all  these  syndromes;  how com-
pletely desensitizing ASIC1a gets activated dur-
ing prolonged acidosis is unknown. Since ex-
tracellular acidosis increases neuronal cell cal-
cium by activating ASIC1a [33, 138], ASIC1a 
activation might enhance brain injury, for exam-
ple during the ischemia associated with stroke. 
Indeed ASIC1a was found to have a significant 
detrimental effect on neuronal survival under 
ischemic conditions [97]. In the focal ischemia 
model,  intracerebroventricular  injection  of 
ASIC1a blockers (amiloride, PcTX1) or knockout 
of the ASIC1a gene protects the brain from 
ischemic injury [97]. Furthermore, post-ischemic 
administration of PcTx1 was found to be neuro-
protective against brain ischemic injury in the 
transient  middle  cerebral  artery  occlusion 
model [149]. In addition and as mentioned be-
fore, there is evidence that ASIC1a functionally 
couples to NMDA receptors. Consequently, acti-
vation  of  ASIC1a  may  exacerbate  neuronal 
death  during  ischemia  also  by  coupling  to 
NMDA receptors [150]. These findings identify 
ASIC1a as an emerging non-classical excitotoxic 
therapeutic target for combating stroke [151].  
 
In a mouse model for experimental autoimmune 
encephalomyelitis (EAE), ASIC1a mRNA is up-
regulated and genetic disruption of ASIC1 or 
pharmacological inhibition by amiloride amelio-
rates disease severity and axonal loss in EAE 
mice [98]. Axonal degeneration may be initiated 
by activation of ASIC1a localized to dendrites or 
cell bodies or alternatively, ASIC1a may be ab-
normally distributed to demyelinated axons in 
inflamed EAE lesions [98]. 
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In the PNS, ASIC1a is expressed together with 
other ASICs (ASIC1b, 2a, 2b, and 3) in sensory 
neurons of the dorsal root ganglion (DRG) and 
trigeminal ganglion (TG) [123, 152, 153]. More-
over,  homomeric  ASIC1a  and  heteromeric 
ASIC1a/2a are the predominant ASICs in neu-
rons of the spinal dorsal horn [130, 154]. Dur-
ing inflammation, ASIC1a expression increases 
in the DRGs [123, 155] and the spinal horn 
[114, 154]. Increased ASIC1a expression most 
likely contributes to enhanced pain during in-
flammation [100, 156]. In agreement with this 
hypothesis, spinal infusion of PcTx1 or ASIC1a 
antisense oligonucleotides attenuated thermal 
and mechanical hypersensitivity [154], suggest-
ing that ASIC1a contributes to central sensitiza-
tion.   
 
In summary, in the last decade we learned a lot 
about the roles of ASIC1a in the central nervous 
system  and  in  neuropathological  conditions. 
Many aspects of its action remain mysterious, 
however, suggesting that the study of ASIC1a 
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